Cannabis + Yunzhi, this medical cannabis pharmaceutical company is secret: 90% of colon cancer cells can be killed

The world's second largest cancer - colorectal cancer, its five-year rate is about 65%, second only to the first killer lung cancer. In the past few years, Cannabotech scientists have been developing a "comprehensive anti-colon cancer" drug, and their latest studies have shown that drugs can kill more than 90% of colon cancer cells.

According to CannaBotech, the unique combination of cannabin and mushroom extract has completed a test of various colon cancer subtypes, representing different molecular changes in these colon cancer subtypes. The results of their cell model studies were shocked, indicating that their composition can kill more than 90% of colon cancer cells.

It can be said that a source of severity is easy to plant cannabis and mushrooms can be used to save millions of life every year. The results show that Cannabotech's Integrative-Colrative-Colon cannabin + mushroom extract product composition is more effective than each of the cannabisines, and there is a strong synergistic effect between active ingredients.

In addition to the anticancer cannabin ingredients (specific matching without disclosure) Extract. This special extract has been known for people, and has been approved as a tumor therapy in Japan, Taiwan and South Korea.

Trametes Mushroom is Yunzhi mentioned in our Chinese medicine, and Western medicine is summarized as Medicinal Mushrooms (medical mushroom). Some people are easy to confuse Yunzhi and Ganoderma lucidum first, let's take a look at them:

1, the subject is different. Yunzhi is a porous bacteria, porcella, Yunzhi, Ganoderma lucidum, is a porous bacteria, Ganmaida, Ganoderma lucidum, both with different sectors, and different genus.

2, the shape of the appearance is different. Yunzhi is no sterile handle, black and white, with a textile and fiber structure. And Ganoderma lucidum is a bacteria, which is the difference between the two appearance.

3, the main efficacy is different. The main effect of Yunzhi is to improve the body's immune function, inhibit tumor growth, keep liver liver, relieve white blood cell low, etc., the main effect of Ganoderma lucidum is to enhance human immunity, peace of mind, control blood pressure, promote sleep, regulate blood glucose.

In Cancer.gov, it is clearly written, and the polysaccharide K (PSK) in Yuma can enhance the immune system to fight cancer. PSK has been studied in patients with gastric cancer, breast cancer, colorectal cancer and lung cancer. Since the mid-1970s, it has been used as auxiliary treatment for thousands of cancer patients. In Japan, PSK has been safely used in the human body for a long time, and there are very few reports of side effects.

"Cannabotech solution will be launched in Israel and the United States in the second half of 2022, and the company's goal is to medical cannabis treatment of cancer development industry new standards," - Cannabotech CEO Elhanan Shaked.

Powerful anti-cancer combination of marijuana and mushroom

Modern medicine has shown that cannabis has anti-cancer properties and has been used in the form of extract to treat multiple types of tumors. According to evidence-based medicine, many cases of many cases have been completely pending cancer using rso (Rick Simpson Oil).

According to scientists, THC (tetrahydroapta) and CBD (hemp phenol) can kill certain types of cancers in vitro. The mechanism it uses is called "apoptosis", which basically indicates cancer cells to consume themselves. In essence, cannabinoids wrap the cancer cells and limit their eating, cancer cells are forced to die with themselves, and then die.

Although a large number of fact cases are placed in front of it, these natural therapies that naturally give human beings have been isolated. After all, many of the traditional pharmaceutical companies in the world are to sell their anticancer drugs as much as possible, even if the side effects of these drugs are greatly amazing.

According to the Press release of Cannabotech, the company will enter a variety of combined efficacy of its products and standard chemotherapy in the next stage of the United States this year, which is likely to become a new standard for hemp anti-cancer therapy. It is "the last straw" of the pharmaceutical enterprises that have fallen into the heart.